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Abstract
Patients with chronic critical illness (CCI) represent a growing segment of the hospitalized population. Key aspects of
care in CCI patients including tracheostomy, prolonged mechanical ventilation, nutritional support, wound care, and
others require a comprehensive, goal-directed approach. Infectious complications of CCI including pneumonia, tracheobronchitis and urinary tract infection may be caused by nosocomial organisms requiring awareness and adjustment
of treatment regimen. Finally, psychiatric, palliative, rehabilitative components of care impact heavily upon outcomes in
CCI patients. As care that is typically associated with the intensive care unit is extended to the hospital ward, we aim to
increase awareness among providers and outline a systematic approach to deliver high quality, patient centered care to
CCI patients.
Keywords: Chronic critical illness, CCI, Persistent critical illness, Chronic illness, LTACH, Medically complex patients

1. Introduction

H

ospital providers are increasingly faced with
the task of caring for patients whose hospitalization may be prolonged due to chronic critical
illness (CCI).1 Although these patients represent a
small proportion of overall acute inpatient volume,
their management is likely to be complex and timeconsuming. The patient with CCI may transition to
the inpatient hospital service after extended stays in
intensive care unit (ICU); from the pediatric

population after exceeding the age limit of pediatric
hospitals, and other settings where complex illness
is extended over time through intensive clinical
management. Additionally, the Coronavirus Disease-19 (COVID-19) pandemic has led to an increase in acute respiratory failure and ICU
utilization with resultant increases in patients
requiring prolonged hospitalization as they recover
from complications of critical illness.2,3 Often these
patients end up on hospital wards and transition
between services, without progressing overall care
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plans. Providers who take on these cases must
spend time reviewing charted records sometimes
going back months, or even years, and may ﬁnd the
number of complex medical issues challenging to
combine into a uniﬁed plan of care. We believe that
their care can be improved by changing management and communication practices using a multidisciplinary approach. In this article, we discuss
common aspects of long-term hospitalized CCI patient care and outline an objective and systematic
approach for the clinician.

2. Deﬁnitions
Chronic critical illness is loosely deﬁned as the
group of patients who require care typically associated with the ICU setting.4 The concept of prolonged hospitalization does not have an established
deﬁnition but, may be understood as a hospitalization which has lasted for greater than 21 days,
with or without clearly identiﬁed criteria for
discharge and post-discharge disposition.5,6 Patients with CCI are likely to have exhibit a complex
mix of clinical conditions: respiratory failure
requiring prolonged mechanical ventilation via
tracheostomy, gastrostomy tube dependence,
complex wounds, malnutrition, severely decreased
functional status, among and other organ failures.7
Patients undergoing prolonged hospitalization for
CCI commonly have care needs which exceed the
level provided by home visiting nurse agencies,
nursing homes and skilled nursing facilities. Longterm acute care hospitals (LTACH), care settings
which came into being in the 1980s to address the
needs of patients requiring prolonged ventilatory
support have limited bed capacity or may not
support a combination of complex issues such as
hemodialysis and a tracheostomy with ventilator
dependence. The concepts discussed here are fully
applicable to the LTACH patient.

3. Speciﬁc aspects of care
3.1. Tracheostomy and prolonged mechanical
ventilation
CCI patients may exhibit partial or complete
dependence on mechanical ventilation and are
likely to have undergone tracheostomy placement.8
Among hospital discharges with respiratory failure
and invasive mechanical ventilation, an average of
9.6% received tracheostomy in the hospital between
2002-2017.9 Reported rates of tracheostomies utilized during the coronavirus pandemic vary significantly from 16% to 61%, but are likely higher than
pre-pandemic rates.9,10 Factors associated with
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prolonged dependence upon mechanical ventilation
include systemic, respiratory, neurological, and
other conditions. Respiratory illnesses such as
chronic obstructive pulmonary disease and acute
complications including diaphragmatic weakness,
decreased respiratory muscle reserve, and ineffective cough is commonly encountered. Critical illness
neuromyopathy, and psychiatric causes such as
depressed mood or severe anxiety may also
contribute.8
Management objectives for patients chronically
dependent on mechanical ventilation include
weaning from ventilatory support and tracheostomy
care. Several weaning approaches including progressive reduction in pressure support ventilation
(PSV),
progressively
increased
spontaneous
breathing trials, non-invasive ventilation and others
have demonstrated efﬁcacy.11 Weaning protocols
generally share the aim of gradually decreasing
patient dependence on mechanical ventilation with
the ultimate goals of liberation and tracheostomy
decannulation. A protocolized approach to long
term weaning has been shown to be superior to a
non-protocolized approach, independent of a speciﬁc ventilation strategy.12 Some patients may not
completely wean from mechanical ventilation,
particularly in conditions involving progressive
neurological decline. A multi-disciplinary approach
involving respiratory therapy, physical/occupational
therapy and pulmonary medicine is the most likely
to achieve success as factors outside of the respiratory system including overall functional status,
nutrition, alertness, and mood play a large role in
successful weaning.13
Tracheostomy tubes are available in a variety of
conﬁgurations and types (cuffed, uncuffed, with/
without inner cannula) and are chosen based on the
patient's anatomy and mechanical ventilation needs.
Routine care may include humidiﬁcation of inspired
air, tracheal suctioning, cleaning of the inner cannula (if present), and inspection of tube positioning
and cuff pressure, with adjustment as required.
Complications encountered with tracheostomy care
may include bleeding and loss of airway in the immediate post-placement period; obstruction and
partial or complete displacement in the intermediate term; and development of tracheomalacia and
tracheal stenosis in the long-term.8
Red ﬂags, or speciﬁc indicators of an impending
tracheostomy problem, may include gas escaping
through the upper airway or formation of saliva
bubbles at the mouth or nose indicating a malpositioned tube or insufﬁcient cuff pressure. The
tracheostomy may be visibly displaced and require
removal and exchange or repositioning. The inner
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tube may become obstructed with viscous or
inspissated secretions and may require suctioning
or exchange. Options for emergency oxygenation
may include ventilation via the face mask or intubation via vocal cords; in addition, emergency
consultation with surgical, anesthesiology, or pulmonary medicine services should be obtained. Clinicians should engage with tracheostomy care
specialists within their institution including respiratory therapy, otolaryngology, and pulmonary
medicine. The United Kingdom National Tracheostomy Safety Project serves as a resource for
guiding bedside staff in tracheostomy care and
airway emergencies in this population.14 Long term
outcomes are generally poor (one year mortality up
to 78%) but prognosis improves with successful
weaning.15

Total Parental Nutrition (TPN) is the intravenous
supplementation of nutrients and is referred to as
“total” when it is the exclusive feeding method for
the patient. Initiation of parenteral nutrition should
occur when enteral nutrition is not feasible in
malnourished or at-risk patients.20 TPN is administered through a central venous catheter and
generally consists of carbohydrate, lipid, and amino
acid components. TPN provides nutrition but is not
likely to reverse cachexia resulting from various
disease states. Complications of TPN include
venous catheter infection and thrombosis; increased
rates of sepsis, due to fungemia; hepatobiliary
involvement including steatosis, biliary stasis,
cirrhosis; and renal disease through the pathway of
oxalate nephropathy.20
3.3. Complex wound care

3.2. Nutritional support
Malnutrition is highly prevalent in hospital inpatients, up to 60% in some reports and is more
likely to occur in elderly and critically ill patients.16
Malnutrition is associated with increased morbidity,
decreased wound healing, loss of muscle mass and
increased risk of infectious complications. The European Society for Clinical Nutrition and Metabolism
(ESPEN), recommends nutritional screening of inpatients with validated screening tools to assess
malnutrition.17 For those patients who can safely
tolerate oral intake oral nutritional supplementation
high in energy and protein is recommended.17 When
nutritional requirements cannot be met orally,
enteral nutrition is recommended over parenteral
nutrition whenever possible.18 Energy requirements
may be estimated from a prediction equation or
weight-based calculation. Vitamin and trace elements should be supplemented when deﬁciency is
documented or suspected. Nutritional support
should be initiated early in the hospital stay and aim
to meet 75% of the patient's energy or protein requirements to improve clinical outcomes.17
In practice, many patients fail to meet their intake
requirements orally and undergo placement of
nasogastric or gastrostomy tubes for enteral feeding.
Small-bowel placement of feeding tubes is recommended to reduce risk of aspiration despite mixed
evidence of efﬁcacy.18 Upon initiation, patients
should be monitored for refeeding syndrome which
may manifest as hypophosphatemia, hypokalemia
and hypomagnesemia and screened for thiamine
deﬁciency. Enteral nutrition is generally well-tolerated, but patients should be monitored for gastric
residual volume, constipation, diarrhea, vomiting
and abdominal distention.19

Pressure injuries resulting in ulceration and
wound formation frequently occur in critically ill
and immobile patients. Pressure injuries occur
when pressure is applied to the skin overlying a
bony prominence resulting in ischemia. The
sacrum, heel and ischium are common sites in order
of frequency for pressure ulcer formation.21 Moisture accumulation particularly through urinary or
fecal incontinence may accelerate wound formation
and prevent healing. Other risk factors include
malnutrition, cachexia, immunocompromise, and
severe neurological disease.22
Wounds should be monitored for infection which
may present as swelling, erythema, purulent
drainage, wound expansion, and subcutaneous
tunneling. Osteomyelitis of the bony tissues underlying deep wounds is a frequent complication and
often requires surgical debridement, in addition to
antibiotic treatment. Antibiotic therapy should be
based upon cultures, obtained from deeper sites
within the wound, if possible, to avoid culturing superﬁcial contamination and colonizing organisms.23
Treatment of pressure injuries should focus on
pressure off-loading; optimization of existing risk
factors including malnutrition, immobility, and
moisture sources; evaluation for infection and local
wound care.24 Strategies aimed at debridement of
necrotic wound tissue may include wet-to-dry
dressings, high-pressure irrigation, enzymatic
debridement in addition to sharp debridement and
vacuum-assisted closure. Surgical evaluation should
be obtained for wounds with exposed deep tissues,
large amounts of necrosis and other complications
impeding wound healing. Surgical treatment may
include wound excision and closure with skin ﬂaps.
Clinicians should employ a multidisciplinary
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Fig. 1. Sacral wound displaying before (A) and after (B) images over 8 month long period of treatment with pressure off-loading, as well as
collaborative wound care involving hospitalists, nurse wound specialists, and plastic surgeons during a prolonged hospitalization for CCI.

approach involving wound care specialists from
nursing and surgical ﬁelds (see Fig. 1).
3.4. Infectious complications
3.4.1. Tracheobronchitis and pneumonia
Tracheostomy with or without chronic ventilator
support increases the risk for colonization of airways with pathogens and the subsequent development of inﬂammatory processes in the bronchioles,
bronchi and trachea resulting in tracheobronchitis.
Diagnosis of bacterial ventilator-associated tracheobronchitis (VAT) requires the absence of pulmonary inﬁltrates and at least 2 of the following: 1)
fever (>38  C) 2) cough, 3) new or increased production of sputum, 4) rhonchi and wheezing and 5)
bronchospasm.25 Management of tracheobronchitis
is by using antipyretics, mucolytic agents, humidiﬁed oxygen and other supportive measures and
antibiotics in cases of conﬁrmed bacterial infection.
Antibiotic choices should cover potential grampositive and gram-negative pathogens such as
Streptococcus pneumoniae, Methicillin Resistant
Staphylococcus Aureus (MRSA) and Pseudomonas
species.26 Nosocomial viral infections should also be
considered.
Patients with ventilator-associated pneumonia
(VAP) meet criteria for VAT but also have new lung
inﬁltrates.27 As with cases of VAT, initial choices of
antibiotics should cover common culprit pathogens
with consideration for two antipseudomonal agents
of different classes if risk factors for resistance are
present or predisposing lung disease such as bronchiectasis and cystic ﬁbrosis. The duration of treatment is seven days but may be shorter or longer
depending on clinical response.

3.4.2. Complicated urinary tract infection (UTI)
Complications of long-term urinary catheterization (>30 days) include asymptomatic bacteriuria,
Catheter-Associated Urinary Tract Infection (CAUTI), catheter obstruction, renal and bladder calculi
formation associated with urease-producing pathogens, and ﬁstula formation. CA-UTI in patients with
indwelling urethral, suprapubic, or intermittent
catheterization is deﬁned by the presence of symptoms or signs compatible with UTI, along with
P103 colony-forming units (cfu)/mL of P1 bacterial
species in a single catheter urine specimen.28 Signs
and symptoms compatible with CA-UTI include
new onset or worsening of fever, rigors, altered
mental status, malaise, or lethargy with no other
identiﬁed cause; ﬂank pain; costovertebral angle
tenderness; acute hematuria; pelvic discomfort; and
in those whose catheters have been removed,
dysuria, urgent or frequent urination, or suprapubic
pain or tenderness. A urine specimen for culture
should be obtained before starting antimicrobial
therapy for presumed CA-UTI because of the wide
spectrum of potential infecting organisms and the
increased likelihood of antimicrobial resistance.29
Catheter replacement is required in patients who
require an indwelling catheter to hasten resolution
of symptoms and to reduce the risk of subsequent
bacterial colonization and CA-UTI.
CA-UTI and other infections may be caused by
resistant species such as Extended-Spectrum bLactamase (ESBL)eproducing Enterobacteriaceae.
ESBL-producing gram-negative organisms can hydrolyze higher generation cephalosporins that have
an oxyimino side chain such as cefotaxime, ceftazidime, ceftriaxone, and cefepime. The carbapenem
class of antibiotics (meropenem, ertapenem) is the
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preferred agent group for treating ESBL-producing
organisms' infections.
3.4.3. Central lineeassociated bloodstream infections
and fungemia
Most central line infections are primary, rather
than secondary to bacteremia due to other infections. The most common pathogens are grampositive organisms, which should guide initial
antibiotic choices.30 Common gram-negative organisms causing Central LineeAssociated Bloodstream Infections (CLABSIs) include E. coli and
Klebsiella species.30 Appropriate management includes line removal with systemic antibiotic therapy
targeted to the most likely organism. Blood cultures
should be obtained after catheter removal and
initiation of appropriate antibiotic therapy to document clearance of the organism. Treatment should
be targeted based on susceptibility results. The
duration is 7e14 days for uncomplicated infections.
Complicated cases may require a longer course of
treatment.31
Candida species are the fourth most isolated organisms in bloodstream infections and are associated with a mortality rate up to 40%.31 Identiﬁcation
of yeast cells in the blood and on the catheter indicates candidemia. Risk factors for candidemia
include central venous or hemodialysis-associated
catheters, use of broad-spectrum antimicrobial
agents, TPN, ICU stay or mechanical ventilation for
more than three days, transplantation, and neutropenia.32 Candidemia can present as an isolated
fever or septic shock. It may also be associated with
endocarditis, meningitis, and peritonitis. Initial
treatment of candidemia and invasive candidiasis
should include an echinocandin (caspofungin,
micafungin, or anidulafungin) and intravascular
device removal if feasible.32 A funduscopic examination is also necessary to exclude endophthalmitis.
Other infectious complications include Clostridium
difﬁcile colitis, acalculous cholecystitis, wound and
PEG tube insertion site infections.
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